Non-melanoma skin cancer patients who are seeking a non-invasive treatment alternative may find Image Guided Superficial Radiation Therapy (also called Image Guided Superficial Radiotherapy, or IG-SRT) to be a favorable solution. Recent studies show that patients who undergo IG-SRT have seen an effectiveness rate of 99.4%. If you are still in the process of determining whether IG-SRT is right for you, we encourage you to take a moment to observe these before and after photos for Basal cell carcinoma and Squamous cell carcinoma patients who chose Image-Guided Superficial Radiotherapy over conventional Mohs surgery.
BASAL CELL CARCINOMA
While every situation is unique, this patient shows a favorable outcome after the treatment of Basal cell carcinoma with IG-SRT.
SQUAMOUS CELL CARCINOMA
By directly targeting the lesion, IG-SRT preserves the surrounding healthy skin. This leads to a more appealing outcome, increased self-confidence and self-image, and allows you to maintain your daily schedule and pursue your favorite activities.
Visit our blog to learn about other patients who successfully beat non-melanoma skin cancer using IG-SRT.1
Our skin cancer information specialists would be happy to provide you with the information you need to make a better-informed treatment decision.
If you have a question, please give us a call.
1 based on results as indicated by local control rates.
According to skin cancer statistics published by the American Academy of Dermatology, skin cancer is the most common cancer in the United States, with current estimates showing that one in five Americans will develop skin cancer in their lifetime. Research estimates also show that non-melanoma skin cancer, including Basal cell carcinoma and Squamous cell carcinoma, will affect more than 3 million Americans every year.
When it’s time to treat non-melanoma skin cancer, patients and their physicians often have several options from which to choose. Basal cell carcinoma and Squamous cell carcinoma, the two most common forms of non-melanoma skin cancer, can often be treated with Image Guided Superficial Radiation Therapy. IG-SRT is performed with SRT-100 Vision™, a highly-effective system manufactured in the United States by Sensus Healthcare. The SRT-100 Vision™ system provides the ability to “see and treat”, a skin cancer treatment process where the radiotherapist is able to see and target the cancer throughout the treatment session.
If you’ve been diagnosed with non-melanoma skin cancer and have been told you need Mohs surgery, what you really need is a second opinion to determine whether IG-SRT might be a better option. To learn more about IG-SRT, the non-surgical alternative, call now to speak with a skin cancer information specialist. We’ll help you to get the information you need so that you and your doctor can make a better-informed treatment decision. The call is free. 855-222-6858. We also invite you to consult our blog and our FAQ for even more helpful information.